Member Info for Y-Alam

Someone mentioned a retrace to 144 before a move back up...expect the move back up pretty soon now we have hit 144.

Professor on Channel 4 news reporting variant resistance to vaccine

Hi..hi....love your post...some great thinking....how can Tils afford Regeneron CMO????...friendly takeover....or this guy is confident he can turn tils into a multi billion $ company

Sporty....regardless of the hiccups along the way....the investment case in tils has always been strong.....foralumab is worth more than the current market cap alone. CMO from Regeneron would not have taken post if he did not believe in our product. Obviously there is always the chance that Regeneron are doing due diligence by sending in their CMO before takeover. With Regeneron one of the biggest players in maB ...it makes sense that Regeneron are courting us.

The Dr at Biontech...just said it will take 6 weeks to develop new vaccine for new variant...bbc news

I hold both sng and tils.....realisation that treatments are needed slowly coming through.....stil think maBs will be way forward

More likely that vaccine will have a lower effective rate on variant

Non published yet...I think they dont want to scare public....I am just joining up dots.....vaccine identifies covid from the spike protein....variant has a different spike protein....common sense dictates that if the spike protein is different it may make it difficult for vaccine to work or have a lower effective rate which will probably be the case....example from recent history....the flu vaccine was only 10% effective during one year due to new flu strain.....dyor

It is slowly becoming more likely that vaccine will not work on new variant which identifies covid via spike protein which has changed.....treatments are needed

It is slowly becoming more likely that vaccine will not work on new variant which identifies covid via spike protein which has changed.....treatments are needed

This is why treatments such as tils extremely important and this is where vaccines fail to keep up. Mab treatment extremely important..however not a great awareness in UK

Gc has intimated on previous interviews that there are pharmas who would be interested in buying accustem/ stemprint

Fda advisory council approves vaccines....17-4....full approval in days

Approval within days...should be good long term for trx

Bb...been here forever...imo the sp does not need talking down...the bod doing a good enough job.
With the early complications of the vaccines coming out....the need for treatments are slowly becoming more apparent...however the damage done by the bod has investors looking elsewhere. We live in hope.

Ninja totally agree...looks like it is heading lower...totally lost faith in Bod...just non stop down every day with no respite...I am sick of the vague language in the calls...followed by more calls with delays...and more vague language...Nasdaq tracking 74p....unfortunately this is not down because of bad news...its down because of the constant missed deadlines from board. Why would you destroy your own share price...still no sight or actual dates regarding accustem. We still have to endure sell off before xmas.....doubt we will get any of the news that we were promised before xmas.

Mr India...I think the drop was part exercised drop to allow some to pick up stock cheap. What happens on an initial spike...the share rise is stymied to allow others that missed out on the rise to get in cheaper...I expect sp to be back above 0.5 next week.

Spinnaker...well put....not much more to be said here.

Chester I would agree...looks like just people trading....some resistance at 43-45.

Lets.....totally agree.